Researchers long have known that some portion of the risk of developing cancer is hereditary and that inherited genetic errors are very important in some tumors but much less so in others.
Dec 22, 2015
0
180
(HealthDay)—For patients with acute myeloid leukemia (AML), patient-performed daily spirometry (forced expiratory volume in one second [FEV1]) is effective for early identification of pneumonia, according to a study published ...
Dec 21, 2015
0
0
Researchers at the Penn State College of Medicine, working with Chinese and American colleagues, have discovered a novel way to enhance and restore cancer suppressor activity in B-cell acute lymphoblastic leukemia, resulting ...
Dec 15, 2015
0
29
Midostaurin added to standard chemotherapy is the first targeted treatment to improve survival of a high-risk, genetically defined subgroup of patients with acute myeloid leukemia (AML), reported Dr. Richard Stone, of Dana-Farber ...
Dec 7, 2015
0
0
(HealthDay)—Excess relative risk of computed tomography (CT) scans for quantification of cystic fibrosis (CF) can be calculated, according to a letter published in the Dec. 1 issue of the American Journal of Respiratory ...
Dec 6, 2015
0
4
U.S. regulators have approved the first generic version of one of the first very effective—and expensive—cancer drugs, Gleevec, which costs about $10,000 a month.
Dec 4, 2015
0
6
When preliminary tests show that a new drug has remarkable effectiveness against a lethal illness, everyone wants to know how it works. Often, a mechanism of action is hard to pin down, but when it can be, a candidate drug's ...
Nov 30, 2015
0
55
An experimental chemotherapy kills leukemia cells that are abundant in proteins critical to cancer growth, according to new research from Weill Cornell Medicine.
Nov 26, 2015
0
55
Pevonedistat is a first-in-class, investigational small-molecule inhibitor of the NEDD8-activating enzyme, explained Shah. "This enzyme is part of the ubiquitin-proteasome system, which is the target of a number of FDA-approved ...
Nov 11, 2015
0
22
FUJIFILM Corporation today announced to conduct a clinical trial of its anti-cancer drug FF-10101 in patients with relapsed or refractory acute myeloid leukemia (AML) in the United States next year. FF-10101 is a new drug ...
Nov 10, 2015
0
13
